These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1216 related items for PubMed ID: 25726417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis.
    Siris ES, Modi A, Tang J, Gandhi S, Sen S.
    Curr Med Res Opin; 2014 Jan; 30(1):123-30. PubMed ID: 24102262
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Osteoporosis Diagnosis and Management in Long-Term Care Facility.
    Aguilar EA, Barry SD, Cefalu CA, Abdo A, Hudson WP, Campbell JS, Reske TM, Bonafede M, Wilson K, Stolshek BS, Paoli CJ, Tran N, Cheng LI.
    Am J Med Sci; 2015 Nov; 350(5):357-63. PubMed ID: 26517500
    [Abstract] [Full Text] [Related]

  • 6. Retrospective analysis of eligibility for denosumab in patients presenting with osteoporotic fractures and renal impairment treated by orthogeriatric service at Middlemore Hospital.
    Kang MY, Besley J, Sun T, Paul S.
    N Z Med J; 2020 May 22; 133(1515):16-24. PubMed ID: 32438373
    [Abstract] [Full Text] [Related]

  • 7. Predictors of Hip Fracture Despite Treatment with Bisphosphonates among Frail Older Adults.
    Zullo AR, Sorial MN, Lee Y, Lary CW, Kiel DP, Berry SD.
    J Am Geriatr Soc; 2020 Feb 22; 68(2):256-260. PubMed ID: 31580488
    [Abstract] [Full Text] [Related]

  • 8. Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population.
    Keshishian A, Boytsov N, Burge R, Krohn K, Lombard L, Zhang X, Xie L, Baser O.
    J Manag Care Spec Pharm; 2017 Nov 22; 23(11):1178-1190. PubMed ID: 29083977
    [Abstract] [Full Text] [Related]

  • 9. Low incidence of anti-osteoporosis treatment after hip fracture.
    Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY.
    J Bone Joint Surg Am; 2008 Oct 22; 90(10):2142-8. PubMed ID: 18829912
    [Abstract] [Full Text] [Related]

  • 10. Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults.
    Zullo AR, Zhang T, Lee Y, McConeghy KW, Daiello LA, Kiel DP, Mor V, Berry SD.
    J Am Geriatr Soc; 2019 Apr 22; 67(4):768-776. PubMed ID: 30575958
    [Abstract] [Full Text] [Related]

  • 11. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A, Kruse M, Agodoa I, Silverman S, Orwoll E.
    Bone; 2014 Feb 22; 59():105-13. PubMed ID: 24231131
    [Abstract] [Full Text] [Related]

  • 12. Disparities in osteoporosis treatments.
    Liu Z, Weaver J, de Papp A, Li Z, Martin J, Allen K, Hui S, Imel EA.
    Osteoporos Int; 2016 Feb 22; 27(2):509-19. PubMed ID: 26216226
    [Abstract] [Full Text] [Related]

  • 13. Incidence and risk of venous thromboembolism among Taiwan osteoporotic fracture population under osteoporosis pharmacological treatments.
    Lin TC, Lee CH, Yang CY, Yang YH, Lin SJ.
    J Clin Endocrinol Metab; 2014 May 22; 99(5):1599-607. PubMed ID: 24606074
    [Abstract] [Full Text] [Related]

  • 14. Clinical, behavioral, and treatment differences in nursing facility residents with dementia, with and without pseudobulbar affect symptomatology.
    Zarowitz BJ, O'Shea T.
    Consult Pharm; 2013 Nov 22; 28(11):713-22. PubMed ID: 24217191
    [Abstract] [Full Text] [Related]

  • 15. Challenges in the Pharmacological Management of Nursing Home Residents with Overactive Bladder or Urinary Incontinence.
    Zarowitz BJ, Allen C, O'Shea T, Tangalos EG, Berner T, Ouslander JG.
    J Am Geriatr Soc; 2015 Nov 22; 63(11):2298-307. PubMed ID: 26503458
    [Abstract] [Full Text] [Related]

  • 16. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment.
    Zarowitz BJ, O'Shea T.
    J Manag Care Pharm; 2012 Oct 22; 18(8):598-606. PubMed ID: 23127147
    [Abstract] [Full Text] [Related]

  • 17. Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance.
    Brookhart MA, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Patrick AR, Mogun H, Solmon DH.
    Am J Med; 2007 Mar 22; 120(3):251-6. PubMed ID: 17349448
    [Abstract] [Full Text] [Related]

  • 18. Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
    Bonafede MM, Shi N, Bower AG, Barron RL, Grauer A, Chandler DB.
    Osteoporos Int; 2015 Mar 22; 26(3):1203-12. PubMed ID: 25567774
    [Abstract] [Full Text] [Related]

  • 19. Compliance with osteoporosis medications.
    Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA.
    Arch Intern Med; 2005 Nov 14; 165(20):2414-9. PubMed ID: 16287772
    [Abstract] [Full Text] [Related]

  • 20. Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review.
    Fujiwara S, Miyauchi A, Hamaya E, Nicholls RJ, Weston A, Baidya S, Pinto L, Barron R, Takada J.
    Arch Osteoporos; 2018 Mar 22; 13(1):34. PubMed ID: 29564555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.